CELEX: 62021TN0149
Language: en
Date: 2021-03-18 00:00:00
Title: Case T-149/21: Action brought on 18 March 2021 — UGA Nutraceuticals v EUIPO — Vitae Health Innovation (VITADHA)

10.5.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 182/62
            
         
      Action brought on 18 March 2021 — UGA Nutraceuticals v EUIPO — Vitae Health Innovation (VITADHA)
      (Case T-149/21)
      (2021/C 182/84)
      Language of the case: English
      
         Parties
      
      
         Applicant: UGA Nutraceuticals Srl (Gubbio, Italy) (represented by: M. Riva, J. Graffer and A. Ottolini, lawyers)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Vitae Health Innovation SL (Montmeló, Spain)
      
         Details of the proceedings before EUIPO
      
      
         Proprietor of the trade mark at issue: Applicant before the General Court
      
         Trade mark at issue: International registration designating the European Union in respect of the mark VITADHA — International registration designating the European Union No 1 352 764
      
         Procedure before EUIPO: Opposition proceedings
      
         Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 15 January 2021 in Case R 2719/2019-4
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision by declaring the signs dissimilar and admitting the opposed application to registration;
               
            
                  —
               
               
                  order the adverse parties to bear the costs of the present proceedings.
               
            
         Plea in law
      
      
                  —
               
               
                  Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.